European Notebook: Agreements On Sovaldi, Olysio Pricing; Drug Shortages Increase; Rawlins Returns As Regulator
Executive Summary
Patient access to the new generation of hepatitis C therapies is set to improve in Europe as pricing negotiations conclude, but concerns increase that a number of other marketed drugs are suffering supply shortages.